• Contact us: 01476 247 007
    MHRA and EMA latest guidance on BrexitMHRA and EMA latest guidance on BrexitMHRA and EMA latest guidance on BrexitMHRA and EMA latest guidance on Brexit
    • How can we help
      • Pharmacovigilance
        • National contact person for pharmacovigilance – post Brexit
        • Pharmacovigilance Standard Operating Procedure Audits
        • Post Marketing Pharmacovigilance Support
        • Clinical Trial Pharmacovigilance Support
        • EU QPPV Provision
        • Quality & Compliance
        • Risk Assessment and Management
        • Signal Detection and Management
      • Medical Writing
      • Patient Information
      • Regulatory
      • Market Authorisation Holding
    • Brexit
    • Our Partners
      • Marti Farm
      • Affiliates
      • Medilink
      • External Team
    • News
    • Get in touch
    What's it like working as an intern at Pure Drug Safety?
    Summer internships at Pure Drug Safety
    23rd October 2020
    Merry Christmas from the PDS team
    Merry Christmas from us all at PDS!
    21st December 2020

    MHRA and EMA latest guidance on Brexit

    23rd October 2020
    MHRA post-transition period information from Pure Drug Safety

    MHRA post-transition period information from Pure Drug SafetyAs at 23 October 2020, the situation regarding a Deal or No Deal Brexit is extremely fluid.

    As such, rather than bombard you with our guesses and interpretations of what may or may not happen, we would rather give you direct links to the MHRA latest guidance HERE and the EMA latest guidance HERE on Brexit so you can see for yourself what the latest information available is.

    However, at present, please be aware that this guidance is currently aimed at a deal for Brexit being agreed.

    Please check back regularly for more updates as we have them.

    Share

    Related posts

    MHRA post-transition period information from Pure Drug Safety
    3rd September 2020

    MHRA post-transition period information


    Read more
    What happens after Brexit for Pharmacovigilance and Regulatory?
    12th February 2020

    What happens after Brexit for Pharmacovigilance and Regulatory?


    Read more
    Pharmacovigilance (QPPV) provision post-Brexit
    7th February 2020

    Pharmacovigilance (QPPV) provision post-Brexit


    Read more

    PLEASE NOTE OUR NEW PHONE NUMBER AS OF 1st JUNE 2021
    Call our team +44(0) 1476 247 007
    email info@puredrugsafety.com



    Sign up for our newsletter

    Pure Drug Safety Ltd

    Pure Drug Safety Ltd · 7 months ago
    @PureDrugSafety



    Many clients have already put their NCPP in place with us here at PDS and are ready for January 2022.

    Read more 👉 https://t.co/6mnM9Dzoma

    #NationalContactPerson #KnowledgeablePerson #ExperiencedQppv https://t.co/rS2W4PZbDv

    View on Twitter


    0

    0

    © 2019 - 2022 Pure Drug Safety.
    As of 1st June 2021 NEW OFFICE & REGISTERED ADDRESS: BioCity Nottingham, Pennyfoot Street, Nottingham, NG1 1GF, UK
    Pure Drug Safety Limited is a company registered in England and Wales. Registered Company Number 7702236. VAT Registered Number 117 966 288
    For our GDPR and Privacy Policy click here
    Designed by Gather Creative | Content managed by Tailored Marketing Solutions | Built + Hosted by GIGER MEDIA